Showing results (561-570 of 571) with videos related to

Sort By:
Pageof 58
Environmental Health : a Global Access Science Source|December 17, 2008
Centers for Oceans and Human Health: a unified approach to the challenge of harmful algal bloomsDeana L Erdner, Julianne Dyble, Michael L Parsons, et al.
Physical Review Letters|May 1, 2001
Low-energy measurement of the 7Be(p,gamma)8B cross sectionF Hammache, G Bogaert, P Aguer, et al.
Marine Mammal Science|August 26, 2025
Saxitoxin linked to deaths of northern fur seals in the Southeast Bering SeaKathi A Lefebvre, Chelsea M Campbell, Lauren M Divine, et al.
Nature Genetics|March 20, 2019
A genome-wide algal mutant library and functional screen identifies genes required for eukaryotic photosynthesisXiaobo Li, Weronika Patena, Friedrich Fauser, et al.
Limnology and Oceanography Letters|February 10, 2025
Tracking a large-scale and highly toxic Arctic algal bloom: rapid detection and risk communicationEvangeline Fachon, Robert S Pickart, Gay Sheffield, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical TrialLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
Journal of Hepatology|September 28, 2025
Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitisGideon M Hirschfield, Kris V Kowdley, Palak J Trivedi, et al.
Respiratory Research|October 20, 2021
Dual inhibition of αvβ6 and αvβ1 reduces fibrogenesis in lung tissue explants from patients with IPFMartin L Decaris, Johanna R Schaub, Chun Chen, et al.
Pageof 58